Denator

company

About

Denator develops and markets products that stabilize biological tissues and fluids from the moment of sampling.

  • 11 - 50

Details

Last Funding Type
Series Unknown
Last Funding Money Raised
$1.70M
Industries
Biotechnology,Clinical Trials,Manufacturing,Medical
Founded date
Jan 1, 2004
Number Of Employee
11 - 50
Operating Status
Active

Denator develops and markets products that stabilize biological tissues and fluids from the moment of sampling.

Utilizing a patent-pending technology to instantly and completely stop the degradation process and maintain sample stability thereafter, Denator aims to become the leading supplier of instruments and consumables that enable scientists to stabilize biological tissues and fluids at the moment of sampling thereby enhancing the quality and value of subsequent analytical results.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
3
$4.52M
Denator has raised a total of $4.52M in funding over 2 rounds. Their latest funding was raised on Jan 10, 2011 from a Series Unknown round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Jan 10, 2011 Series Unknown $1.70M 4 Detail
Feb 1, 2007 Series B $2.16M 1 Detail
Apr 20, 2006 Series A $664K 1 Detail

Investors

Number of Lead Investors
Number of Investors
4
Denator is funded by 4 investors. Servisen Holding and Wikow Ventures are the most recent investors.
Investor Name Lead Investor Funding Round
Servisen Holding Series Unknown
Wikow Ventures Series Unknown
SGP Group Series Unknown
T-bolaget Series Unknown